Her $0 Medicare Plan Was Perfect Until the Cancer Diagnosis

A 68-year-old retiree picked the $0-premium Medicare Advantage plan three years ago because she was healthy, her doctors were in-network, and the gym membership was a nice extra. In June she was diagnosed with stage III breast cancer. The first oncologist she wanted was out-of-network. The second one was in-network but needed prior authorization for the PET scan, then for the chemo regimen, then for the targeted therapy. Her plan’s in-network out-of-pocket maximum is the number she remembered from the brochure. The number she will actually pay is higher.

This is the trade-off Medicare Advantage hides in plain sight. The premium is real. So is the cap. But the cap covers less than most enrollees think, and the access limits are what bite in a sick year. If you are healthy and your doctors are in-network, none of this changes your math. If you have just been handed a serious diagnosis, keep reading.

The advertised cap covers less than enrollees expect

Two things sit outside a Medicare Advantage plan’s advertised in-network out-of-pocket maximum, and a cancer year hits both.

The first is Part D drug spending. The Inflation Reduction Act capped annual out-of-pocket Part D costs at $2,100 in 2026, which is a real protection. But that cap runs parallel to the medical cap, not inside it. The average Medicare Advantage in-network out-of-pocket limit is $5,421 in 2026, according to KFF. Add the drug cap and a sick enrollee can face roughly $7,500 in combined Part A, Part B, and Part D out-of-pocket exposure before a single out-of-network bill arrives.

The second is out-of-network care. The federal in-network MOOP ceiling is $9,250 for 2026, and the federal combined in-network and out-of-network MOOP ceiling for PPO plans is $13,900. The average combined in-network and out-of-network limit on PPO plans is about $9,825. HMO plans usually do not cover out-of-network care at all outside of emergencies, which can turn a referral to an NCI-designated cancer center into a full-price bill rather than a cost-shared one. The advertised cap and the worst-case cap are different numbers, and the brochure rarely puts them next to each other.

The non-dollar catch

Prior authorization is where the real friction lives. Imaging, infusion drugs, surgical procedures, skilled nursing transfers, and durable medical equipment routinely require plan approval before the claim will pay. A denial is appealable. An appeal takes time. In oncology, time is the variable that matters most, and it does not show up in any cost table.

Network limits compound the same problem. The oncologist who specializes in your specific subtype may not contract with your plan. The hospital that runs the relevant clinical trial may not either. Original Medicare with a Medigap supplement does not work this way: any provider that accepts Medicare accepts the plan, and prior authorization for most services does not exist. That is what the higher premium buys.

The switch back is the trap

The obvious move after a diagnosis is to leave Medicare Advantage for Original Medicare plus Medigap. It is rarely that simple. A first-time Advantage enrollee has a 12-month trial right to return to Original Medicare with guaranteed-issue Medigap. After that window, in most states, a Medigap insurer can medically underwrite the application and decline coverage or rate it up. A new cancer diagnosis is the worst possible time to apply under underwriting. A handful of states, including New York, Connecticut, Massachusetts, and Maine, offer broader continuous or annual guaranteed-issue rights. Most do not.

What to do

If you are the reader in this scenario, three actions matter this week.

• Call the plan and ask for the specific in-network oncology providers and cancer centers in writing, then confirm whether the treatment center your oncologist recommends is in or out. If it is out, ask whether your plan has a tiered or PPO structure that covers it at the combined cap, or whether you owe full charges.
• Check your Medicare Advantage trial-right window. If you enrolled in your first Advantage plan within the last 12 months, you can return to Original Medicare with guaranteed-issue Medigap. Outside that window, check your state’s specific rules before assuming you have been underwritten out of the option.
• Document every prior authorization request and denial with dates. The expedited appeal process for urgent care decisions runs on a 72-hour clock, and the paper trail is what enforces it.

Medicare Advantage can be the right answer for many enrollees. It is simply a different answer in a sick year than in a healthy one, and the gap between those two answers is the part the premium does not advertise.

Sources: CMS 2026 Medicare Parts A & B Premiums and Deductibles fact sheet; KFF Medicare Advantage 2026 analysis; Medicare.gov Part D cost rules. Figures reflect 2026 plan-year rules.